Vaccine R&amp;D success rates and development times (Q74663165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Vaccine R&D success rates and development times (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

Struck MM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

591-593

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt0596-591

12 November 2019

exact match

0 references

cites work

Immunity to diphtheria in northern Norway and northwestern Russia

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Regulatory considerations in vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Reappraisal of existing methods for potency testing of vaccines against tetanus and diphtheria.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0596-591

7 January 2021

Identifiers

DOI

10.1038/NBT0596-591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630948%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference